Russell Investments Group’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-23,774
Closed -$1.25M 3307
2020
Q3
$1.25M Sell
23,774
-8,840
-27% -$366K ﹤0.01% 1956
2020
Q2
$1.08M Sell
32,614
-23,687
-42% -$754K ﹤0.01% 2009
2020
Q1
$1.53M Sell
56,301
-48,126
-46% -$1.34M ﹤0.01% 1614
2019
Q4
$2.06M Buy
104,427
+13,409
+15% +$214K ﹤0.01% 1723
2019
Q3
$1.18M Buy
+91,018
New +$1.1M ﹤0.01% 1933
2018
Q2
Sell
-21,669
Closed -$393K 3000
2018
Q1
$393K Buy
21,669
+3,100
+17% +$51.7K ﹤0.01% 2534
2017
Q4
$255K Sell
18,569
-4,500
-20% -$60.8K ﹤0.01% 2610
2017
Q3
$427K Sell
23,069
-28,954
-56% -$484K ﹤0.01% 2495
2017
Q2
$880K Sell
52,023
-108,937
-68% -$1.66M ﹤0.01% 2176
2017
Q1
$2.15M Buy
160,960
+142,012
+749% +$2.22M ﹤0.01% 1720
2016
Q4
$284K Buy
+18,948
New +$250K ﹤0.01% 2634

Russell Investments Group's MNTA Position: Q4 2020 in Review

Russell Investments Group sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 23,774 shares — an estimated $1.25M sold.

Russell Investments Group first reported a position in MNTA in Q4 2016 and held it in 11 quarters. The position peaked at $2.15M in Q1 2017. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

  • Russell Investments Group reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • Russell Investments Group sold 23,774 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $1.25M.
  • Russell Investments Group first reported a position in Momenta Pharmaceuticals, Inc. in Q4 2016 and held it in 11 quarters.
  • Russell Investments Group's Momenta Pharmaceuticals, Inc. position peaked at $2.15M in Q1 2017.
  • 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Russell Investments Group's 13F filing for Q4 2020, filed 8 Feb 2021.